Riho Tapfer, director of the Association of Pharmaceutical Manufacturers of Estonia (APME), explains that a modern healthcare system and better medical care will require the widespread adoption of electronic health information which, in turn, allows for changes in important areas including prevention and more personalized care tailored specifically to a patient’s genetic profile and needs.
In 2007, APME and the Estonian Generic Medicines Association (EGMA) merged, which is something that we have not experienced in the other markets where we went. Why was that?
"If we have one advantage compared to other countries in the EU is our clinical excellence and the cheap operational costs and to this purpose Estonia should look to attract more CROs."
